Duration of dual antiplatelet treatment with clopidogrel and aspirin in patients with acute coronary syndrome

Optimized Duration of Clopidogrel Therapy Following Treatment with the Endeavor Zotarolimus-Eluting Stent in Real-World Clinical Practice (OPTIMIZE) Trial: Rationale and design of a large-scale, randomized, multicenter study

(2012) Fausto Feres et al.   AMERICAN HEART JOURNAL

Short- Versus Long-Term Duration of Dual-Antiplatelet Therapy After Coronary Stenting

(2012) Marco Valgimigli et al.   CIRCULATION

Duration of Dual Antiplatelet Therapy and Long-Term Clinical Outcome After Coronary Drug-Eluting Stent Implantation

(2012) Tomohisa Tada et al.   Circulation-Cardiovascular Interventions

Lower risk of stent thrombosis and restenosis with unrestricted use of ‘new-generation’ drug-eluting stents: a report from the nationwide Swedish Coronary Angiography and Angioplasty Registry (SCAAR)

(2012) Giovanna Sarno et al.   EUROPEAN HEART JOURNAL

ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation

(2012) et al.   EUROPEAN HEART JOURNAL

A New Strategy for Discontinuation of Dual Antiplatelet Therapy

(2012) Byeong-Keuk Kim et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Six-Month Versus 12-Month Dual Antiplatelet Therapy After Implantation of Drug-Eluting Stents

(2011) Hyeon-Cheol Gwon et al.   CIRCULATION

ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: The Task Force for the management of acute coronary syndromes (ACS) in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC)

(2011) et al.   EUROPEAN HEART JOURNAL

Rationale and design of the dual antiplatelet therapy study, a prospective, multicenter, randomized, double-blind trial to assess the effectiveness and safety of 12 versus 30 months of dual antiplatelet therapy in subjects undergoing percutaneous coronary intervention with either drug-eluting stent or bare metal stent placement for the treatment of coronary artery lesions

(2010) Laura Mauri et al.   AMERICAN HEART JOURNAL

Risk score to predict serious bleeding in stable outpatients with or at risk of atherothrombosis

(2010) G. Ducrocq et al.   EUROPEAN HEART JOURNAL

The Swedish Web-system for Enhancement and Development of Evidence-based care in Heart disease Evaluated According to Recommended Therapies (SWEDEHEART)

(2010) T. Jernberg et al.   HEART

A Randomized Comparison of the Endeavor Zotarolimus-Eluting Stent Versus the TAXUS Paclitaxel-Eluting Stent in De Novo Native Coronary Lesions

(2010) Martin B. Leon et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Duration of Dual Antiplatelet Therapy after Implantation of Drug-Eluting Stents

(2010) Seung-Jung Park et al.   NEW ENGLAND JOURNAL OF MEDICINE

Rationale and design of a randomized, double-blind, placebo-controlled trial of 6 versus 12 months clopidogrel therapy after implantation of a drug-eluting stent: The Intracoronary Stenting and Antithrombotic Regimen: Safety And EFficacy of 6 Months Dual Antiplatelet Therapy After Drug-Eluting Stenting (ISAR-SAFE) study

(2009) Robert A. Byrne et al.   AMERICAN HEART JOURNAL

Antiplatelet Therapy and Stent Thrombosis After Sirolimus-Eluting Stent Implantation

(2009) Takeshi Kimura et al.   CIRCULATION

Ticagrelor versus Clopidogrel in Patients with Acute Coronary Syndromes

(2009) Lars Wallentin et al.   NEW ENGLAND JOURNAL OF MEDICINE

Periprocedural Bleeding and 1-Year Outcome After Percutaneous Coronary Interventions

(2008) Gjin Ndrepepa et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY